Balram Bhargava
Final analysis of Covaxin efficacy out; 65.2 per cent effective against Delta
The efficacy analysis demonstrates Covaxin to be 93.4 per cent effective against severe symptomatic COVID-19 cases
India achieves milestone of conducting 40 crore COVID-19 tests: ICMR
Prof Balram Bhargava said exponential increase in testing has led to early identification, prompt isolation and effective treatment
1 of 1